Sep 4, 2026, 4:20 PMTechnology
Trijya Vakil and Neeraj Visen
More in this Section Trijya Vakil and Neeraj Visen U. SECURITIES AND EXCHANGE COMMISSION Litigation Release No. 26629 / September 4, 2026 Securities and…
Summary
More in this Section Trijya Vakil and Neeraj Visen U. SECURITIES AND EXCHANGE COMMISSION Litigation Release No. 26629 / September 4, 2026 Securities and Exchange Commission v. filed July 10, 2025) SEC Files Settlements with Former Animal Health Company Senior Director and Tippee in Alleged Insider Trading Scheme On September 3, 2026, the Securities and Exchange Commission filed consents and proposed final judgments as to defendants Trijya Vakil and Neeraj Visen in a previously filed action alleging trading in stock of Kindred Biosciences, Inc.
Positives
- SECURITIES AND EXCHANGE COMMISSION Litigation Release No.
Risks & concerns
- The article may not provide enough evidence to validate every implication.
- Execution, cost, adoption, regulation, or security could change the outcome.
Primary sourceLitigation Releaseshttps://www.sec.gov/enforcement-litigation/litigation-releases/lr-26629
Read full article
